D L Andress

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi request reprint Survival following parathyroidectomy among United States dialysis patients
    Bryan Kestenbaum
    Division of Nephrology, University of Washington, Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108, USA
    Kidney Int 66:2010-6. 2004
  2. ncbi request reprint Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure
    D M Kates
    Medical and Research Services, Veterans Administration Medical Center, Seattle, WA 98108, USA
    Am J Kidney Dis 30:809-13. 1997
  3. ncbi request reprint IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice
    D L Andress
    Department of Medicine, University of Washington, Seattle 98105, USA
    Am J Physiol Endocrinol Metab 281:E283-8. 2001
  4. ncbi request reprint Intravenous versus oral vitamin d therapy in dialysis patients: what is the question?
    D L Andress
    Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA
    Am J Kidney Dis 38:S41-4. 2001
  5. ncbi request reprint Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation
    D L Andress
    Department of Medicine, VA Puget Sound Health Care System, Division of Nephrology, University of Washington, Seattle, Washington, USA
    Kidney Int 69:33-43. 2006
  6. ncbi request reprint Antiepileptic drug-induced bone loss in young male patients who have seizures
    Dennis L Andress
    Department of Medicine, Veterans Affairs Puget Sound Health Care System 111A, University of Washington School of Medicine, 1660 S Columbian Way, Seattle, WA 98108, USA
    Arch Neurol 59:781-6. 2002
  7. ncbi request reprint Vitamin D analogs in uremia: integrating medical and nutritional issues
    P Jernigan
    Renal Dietitian, Department of Veteran Affairs, Puget Sound Health Care System, Seattle, WA 98108, USA
    J Ren Nutr 11:3-8. 2001
  8. doi request reprint Adynamic bone in patients with chronic kidney disease
    D L Andress
    Division of Nephrology, University of Washington, Seattle, Washington, USA
    Kidney Int 73:1345-54. 2008
  9. doi request reprint Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease
    O M Gutierrez
    Department of Medicine, Renal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Kidney Int 73:956-62. 2008
  10. ncbi request reprint A novel human insulin-like growth factor binding protein secreted by osteoblast-like cells
    D L Andress
    Department of Medicine, University of Washington, Seattle 98195
    Biochem Biophys Res Commun 176:213-8. 1991

Research Grants

Detail Information

Publications19

  1. ncbi request reprint Survival following parathyroidectomy among United States dialysis patients
    Bryan Kestenbaum
    Division of Nephrology, University of Washington, Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108, USA
    Kidney Int 66:2010-6. 2004
    ..Parathyroidectomy (PTX) can dramatically reduce parathyroid hormone (PTH) and phosphate levels; however, the relationship between PTX and survival is not known...
  2. ncbi request reprint Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure
    D M Kates
    Medical and Research Services, Veterans Administration Medical Center, Seattle, WA 98108, USA
    Am J Kidney Dis 30:809-13. 1997
    ..This study supports recent animal studies showing a direct parathyroid cell effect of phosphate on PTH secretion...
  3. ncbi request reprint IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice
    D L Andress
    Department of Medicine, University of Washington, Seattle 98105, USA
    Am J Physiol Endocrinol Metab 281:E283-8. 2001
    ..The finding that IGFBP-5-(1--169) is bioactive in vivo indicates that the carboxy-terminal portion is not required for this bone anabolic effect...
  4. ncbi request reprint Intravenous versus oral vitamin d therapy in dialysis patients: what is the question?
    D L Andress
    Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA
    Am J Kidney Dis 38:S41-4. 2001
    ..Based on these considerations it is suggested that parenteral vitamin D analogs are superior to pulse oral calcitriol for the long-term control of hyperparathyroidism in dialysis patients...
  5. ncbi request reprint Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation
    D L Andress
    Department of Medicine, VA Puget Sound Health Care System, Division of Nephrology, University of Washington, Seattle, Washington, USA
    Kidney Int 69:33-43. 2006
    ..It is suggested that a re-evaluation of current treatment recommendations is needed and that future research should focus on mechanisms that distinguish potential tissue specific benefits of selective VDR activators in patients with CKD...
  6. ncbi request reprint Antiepileptic drug-induced bone loss in young male patients who have seizures
    Dennis L Andress
    Department of Medicine, Veterans Affairs Puget Sound Health Care System 111A, University of Washington School of Medicine, 1660 S Columbian Way, Seattle, WA 98108, USA
    Arch Neurol 59:781-6. 2002
    ..Long-term antiepileptic drug (AED) therapy is a known risk factor for bone loss and fractures. Vitamin D deficiency is frequently cited as a cause for bone loss in patients who have seizures...
  7. ncbi request reprint Vitamin D analogs in uremia: integrating medical and nutritional issues
    P Jernigan
    Renal Dietitian, Department of Veteran Affairs, Puget Sound Health Care System, Seattle, WA 98108, USA
    J Ren Nutr 11:3-8. 2001
    ..The effective use of these compounds, nevertheless, depends on the coordinated efforts of each member of the health care team to design and implement an integrated treatment protocol that recognizes all aspects of intervention...
  8. doi request reprint Adynamic bone in patients with chronic kidney disease
    D L Andress
    Division of Nephrology, University of Washington, Seattle, Washington, USA
    Kidney Int 73:1345-54. 2008
    ..Future studies will depend on assessing cardiovascular outcomes to determine whether the risk/reward profile for complications related to VDRA and CKD is tolerable...
  9. doi request reprint Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease
    O M Gutierrez
    Department of Medicine, Renal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Kidney Int 73:956-62. 2008
    ..The association between Black race and secondary hyperparathyroidism, independent of known risk factors, suggests that novel mechanisms contribute to secondary hyperparathyroidism in Blacks with chronic kidney disease...
  10. ncbi request reprint A novel human insulin-like growth factor binding protein secreted by osteoblast-like cells
    D L Andress
    Department of Medicine, University of Washington, Seattle 98195
    Biochem Biophys Res Commun 176:213-8. 1991
    ..Because the affinity purified U-2 IGFBPs enhanced IGF-I-stimulated osteoblast mitogenesis, we suggest that one or both of these binding proteins enhance IGF action in bone...
  11. ncbi request reprint Vitamin D treatment in chronic kidney disease
    Dennis L Andress
    Department of Medicine, VA Puget Sound Health Care System and Department of Medicine, University of Washington, Seattle, Washington 98108, USA
    Semin Dial 18:315-21. 2005
    ..Whether they also reduce cardiovascular morbidity and mortality in early CKD, as they appear to do in dialysis patients, remains to be determined...
  12. ncbi request reprint Serum phosphate levels and mortality risk among people with chronic kidney disease
    Bryan Kestenbaum
    Veterans Affairs Puget Sound Health Care System, Division of Nephrology, Mail Stop 111A, 1660 South Columbian Way, Seattle, WA 98108, USA
    J Am Soc Nephrol 16:520-8. 2005
    ..Mortality risk increased linearly with each subsequent 0.5-mg/dl increase in serum phosphate levels. Elevated serum phosphate levels were independently associated with increased mortality risk among this population of patients with CKD...
  13. doi request reprint Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004
    Joseph A Vassalotti
    National Kidney Foundation, Mount Sinai School of Medicine, One Gustave L Levy Pl, Nephrology Box 1243, New York, NY 10029 6574, USA
    Am J Kidney Dis 51:S56-68. 2008
    ..No study specifically examined mineral metabolism trends in a generalizable sample of patients at increased CKD risk...
  14. ncbi request reprint Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD
    Daniel Coyne
    Renal Division, Department of Internal Medicine, Chromalloy American Kidney Center, Washington University, St Louis, MO, USA
    Am J Kidney Dis 47:263-76. 2006
    ..The capsule form of paricalcitol was developed to provide a convenient dosage form for patients with stages 3 and 4 CKD...
  15. pmc Superiority of the Modification of Diet in Renal Disease equation over the Cockcroft-Gault equation in screening for impaired kidney function in Japanese Americans
    Fernando Gerchman
    Division of Metabolism, Endocrinology and Nutrition, VA Puget Sound Health Care System, University of Washington, Seattle, WA 98108, USA
    Diabetes Res Clin Pract 77:320-6. 2007
    ....
  16. ncbi request reprint Bone and mineral guidelines for patients with chronic kidney disease: a call for revision
    Dennis L Andress
    Department of Medicine and Division of Nephrology, University of Washington School of Medicine, Seattle, Washington 98195, USA
    Clin J Am Soc Nephrol 3:179-83. 2008
    ..These studies also suggest avenues for future investigation into nontraditional causes and treatments of cardiovascular disease in patients with chronic kidney disease...
  17. ncbi request reprint Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease
    Dennis L Andress
    University of Washington School of Medicine, Seattle, Washington, USA
    Endocr Pract 14:18-27. 2008
    ..To review approved treatment options for secondary hyperparathyroidism (SHPT) in patients with stages 3 and 4 chronic kidney disease (CKD)...
  18. ncbi request reprint Vitamin D analogs in uremia: integrating medical and nutritional issues
    Peggy Jernigan
    Renal Dietitian, Department of Veteran Affairs, Puget Sound Health Care System, Seattle, WA 98108, USA
    Adv Ren Replace Ther 10:241-7. 2003
    ..The effective use of these compounds, nevertheless, depends on the coordinated efforts of each member of the health care team to design and implement an integrated treatment protocol that recognizes all aspects of intervention...
  19. ncbi request reprint Lower target calcium levels in dialysis patients
    Dennis L Andress
    Semin Dial 15:74. 2002

Research Grants4

  1. MECHANISMS OF IGFBP5 STIMULATION OF BONE CELL FUNCTION
    Dennis Andress; Fiscal Year: 2001
    ....